HD
HDVY.US Health Discovery Cp
- Market cap
- USD 41.2K
- P/E
- -
- P/B
- 107.40x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is HDVY.US undervalued?
Graham numberThe Graham number of Health Discovery Cp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Health Discovery Cp fundamental analysis
No fundamental analysis for Health Discovery Cp yet.
Health Discovery Cp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Health Discovery Cp
Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. Its intellectual property includes Support Vector Machines (SVM), which are mathematical algorithms; and biomarkers that are biological indicators or genetic expression signatures of certain disease states, as well as Fractal Genomic Modeling technology. The company w…
Full company profileHealth Discovery Cp financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Health Discovery Cp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.05M | 1.03M | 44.6K | 43.5K | 45.0K | 44.3K | 1.52M | 1.00K | - | - | - |
| Gross Profit | 1.05M | 1.03M | 44.6K | 43.5K | 45.0K | 44.3K | 1.52M | 1.00K | - | - | - |
| Operating Income | -1.25M | 38.4K | -801K | -954K | -860K | -770K | 1.60M | -1.74M | - | - | - |
| EBITDA | -981K | 306K | -537K | -691K | -597K | -507K | 1.75M | -749K | - | - | - |
| Net Income | -775K | 177K | -587K | -2.07M | -874K | -795K | 1.56M | -759K | - | - | - |
| EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - |
| Balance Sheet | |||||||||||
| Total Assets | 2.27M | 1.58M | 1.50M | 874K | 459K | 153K | 2.31M | 932K | - | - | - |
| Total Liabilities | 1.85M | 805K | 732K | 351K | 744K | 1.15M | 2.78M | 557K | - | - | - |
| Shareholders' Equity | 414K | 772K | 769K | 523K | -285K | -994K | -471K | 375K | - | - | - |
| Cash & Short-term Investments | 796K | 370K | 559K | 196K | 43.5K | 67.00 | 2.30M | 917K | - | - | - |
| Total Debt | - | - | - | - | 175K | 407K | 200K | 212K | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.77M | -736K | -609K | -466K | -314K | -276K | 2.20M | -1.38M | - | - | - |
| Capital Expenditure | 2.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
| Free Cash Flow | -1.77M | -736K | -609K | -466K | -314K | -276K | 2.20M | -1.38M | - | - | - |
| Ratios | |||||||||||
| ROE | -187.1% | 22.9% | -76.4% | -395.8% | - | - | - | -202.4% | - | - | - |
| ROA | -34.2% | 11.2% | -39.1% | -236.7% | -190.3% | -520.0% | 67.5% | -81.4% | - | - | - |
| Net Profit Margin | -73.5% | 17.1% | -1,316.3% | -4,754.1% | -1,944.1% | -1,795.7% | 102.8% | -75,900.0% | - | - | - |
| Debt to Equity | - | - | - | - | - | - | - | 0.57x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Health Discovery Cp dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
| 2015 | - | - | - |
| 2014 | - | - | - |
| 2013 | USD 9.21K | 0.00 | - |
| 2012 | USD 371K | 0.00 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Health Discovery Cp
Ownership data of Health Discovery Cp is not available yet.
Health Discovery Cp company profile
- Company name
- Health Discovery Cp
- Ticker
- HDVY.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 3
- Fiscal year end
- December
- Address
- 2002 Summit Boulevard, NE, Atlanta, GA, United States, 30319
- Phone
- 404 566 4865
- Website
- healthdiscoverycorp.com
About Health Discovery Cp
Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. Its intellectual property includes Support Vector Machines (SVM), which are mathematical algorithms; and biomarkers that are biological indicators or genetic expression signatures of certain disease states, as well as Fractal Genomic Modeling technology. The company was incorporated in 2001 and is based in Atlanta, Georgia.
Health Discovery Cp management
3- Dr. Hong Zhang Ph.D.Chief Science Officer · born 1964
- Dr. Alan K. HauserChief Executive Officer · born 1959
- Dr. Mark A. MooreVice President of Product Development · born 1945